PASS of Paediatric Patients Initiating Selumetinib

Clinical trial NCT05388370 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05388370
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Neurofibromatosis Type 1

Start date: 2022-05-23
Primary completion: 2028-05-23
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.